In charts | India COVID-19 case count, state-wise trends, vaccination data, and other key details

India reported more than 3.62 lakh COVID-19 new cases, according to the May 13 update. Active infections were up by 6,426 cases to 37.10 lakh mark; over 17.72 crore were vaccinations administered till date.

Chaitanya Mallapur

May 13, 2021 / 10:53 IST

Representational image

India’s COVID-19 case tally is now above 2.37 crore with 3,62,727 new cases reported, as per the health ministry’s May 13 update. Cases are below the four lakh mark for the fourth consecutive day, indicating a change in the trend.

May 13 Daily New Cases and Moving Avg

India reported 4,120 new deaths and 3,52,181 new recoveries in the last 24 hours, the latest release showed. More than 17.72 crore vaccinations have been administered across India, according to the May 13 update, with 18,94,991 new vaccinations. The pace of vaccination has slowed down, data suggests.

May 13_BarLine_Daily New Vaccination Vs Daily New Cases

Of the total vaccinations administered to date, 78 percent are recipients of their first dose while 22 percent have received the second dose. Among states, Maharashtra has administered the most 1.90 crore vaccine doses, followed by Rajasthan (1.47 crore) and Gujarat (1.46 crore).

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show